Holding(s) in Company
04 Junho 2009 - 12:28PM
UK Regulatory
TIDMAGI
RNS Number : 4071T
AGI Therapeutics plc
04 June 2009
AGI Therapeutics plc ('AGI')
Holding in Company
AGI was notified on 4 June 2009 that Polar Capital Healthcare Opportunities Fund
no longer had a notifiable interest in AGI's Issued Share Capital.
Contact Information
AGI Therapeutics
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUSUVRKNRNRAR
AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
Notícias em tempo-real sobre AGI da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de AGI Therapeutics plc